Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

25.7%

9 terminated/withdrawn out of 35 trials

Success Rate

35.7%

-50.8% vs industry average

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

4 recruiting1 with results4 withdrawn

Enrollment Performance

Analytics

N/A
7(77.8%)
Phase 4
2(22.2%)
9Total
N/A(7)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials
NCT04103502Withdrawn

In Vivo Kinematics for Subjects Having a MicroPort Medial Pivot or DePuy Attune PCR TKA

Role: collaborator

NCT07391592Active Not Recruiting

Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

Role: lead

NCT06969222Not ApplicableRecruiting

l Investigation of Robotic-assisted TKA (RA-TKA) With Skywalker and Evolution Medial Pivot Knee (eMP Knee)

Role: collaborator

NCT05151315Not ApplicableActive Not Recruiting

NitrX Total Knee Arthroplasty RSA

Role: collaborator

NCT06891807Not ApplicableRecruiting

Comparison of Image Based Robotic Total Knee Arthroplasty vs Imageless Augmented Reality Assisted Total Knee Arthroplasty

Role: collaborator

NCT04814082Not ApplicableRecruiting

Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee Arthroplasty

Role: collaborator

NCT04145401Enrolling By Invitation

Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK

Role: lead

NCT04301622Active Not Recruiting

Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur

Role: lead

NCT04147559Enrolling By Invitation

Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem

Role: lead

NCT04816773Enrolling By Invitation

Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

Role: lead

NCT06142669Recruiting

EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol

Role: lead

NCT02314611Terminated

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator HA Coated Modular Femoral Stems

Role: lead

NCT02239783Active Not Recruiting

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® TL Modular Femoral Stems

Role: lead

NCT03576573Enrolling By Invitation

Post Market Clinical Follow-Up Study Protocol for PROCOTYL® C Acetabular Components

Role: lead

NCT04064008Enrolling By Invitation

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Z Revision Femoral Stems

Role: lead

NCT02285842Active Not Recruiting

Post Market Clinical Follow-Up Study Protocol for CONSERVE® Press-Fit Femoral Components

Role: lead

NCT02149667Active Not Recruiting

Post Market Clinical Follow-up Study Protocol for DYNASTY® BioFoam® Acetabular Components

Role: lead

NCT03865667Active Not Recruiting

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Preserve Femoral Stem

Role: lead

NCT02397746Terminated

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator Cemented Femoral Stems

Role: lead

NCT02589197Completed

Gait and Functional Outcomes Study Following Total Knee Arthroplasty With Medial-pivot or Posterior-stabilized Implants

Role: lead